BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4085887)

  • 1. [Therapeutic effectiveness of polyvinoxide in silicosis and silicotuberculosis].
    Zislin DM; Gol'del'man AG; Katsnel'son BA; Tikhotskaia LI; Rassokhina TG
    Gig Tr Prof Zabol; 1985 Nov; (11):21-5. PubMed ID: 4085887
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of a clinical trial of polyvinoxide in silicosis].
    Glotova KV; Senkevich NA; Kaliteevskaia TN; Pichugin VA; Manzhosova GB
    Gig Tr Prof Zabol; 1981 Aug; (8):14-7. PubMed ID: 7026373
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of polyvinylpyridine N-oxide on pulmonary tissue scleroproteins in experimental silicosis].
    Gel'fon IA
    Gig Tr Prof Zabol; 1978 Sep; (9):54. PubMed ID: 689462
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental silicosis caused by the dust from extra-pure crystalline silicon and the effect of polyvinylpyridine N-oxide on its course].
    Golodnikov IuN
    Gig Tr Prof Zabol; 1978 Dec; (12):31-6. PubMed ID: 720881
    [No Abstract]   [Full Text] [Related]  

  • 5. [Polyvinylpyridine N-oxide (Bay 3504, P-204, PVNO) in the treatment of human silicosis].
    Prügger F; Mallner B; Schlipköter HW
    Wien Klin Wochenschr; 1984 Dec; 96(23):848-53. PubMed ID: 6396971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of polyvinylpyridine N-oxide for treating experimental silicosis and anthracosilicosis].
    Deĭnega VG; Bolonova LN; Sukhanov VV; Zemliakova LF; Tkachuk SV
    Gig Tr Prof Zabol; 1977; (6):25-8. PubMed ID: 892540
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combined treatment of experimental silicotuberculosis with poly-2-vinylpyridine-N-oxide and isoniazid].
    Frolova NN; Ozerova LV; Mordovskoĭ GG
    Probl Tuberk; 1975; (3):67-9. PubMed ID: 1135207
    [No Abstract]   [Full Text] [Related]  

  • 8. [Advances in the study of anti-silicotic agents].
    Huang FZ; Li QL; Qu SJ
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Apr; 9(2):118-21. PubMed ID: 3527609
    [No Abstract]   [Full Text] [Related]  

  • 9. Poly (2-vinylpyridine 1-oxide) in silicosis therapy: effective molecular weight.
    Hasirci VN; Holt PF
    Int Arch Occup Environ Health; 1977; 38(3):177-88. PubMed ID: 832913
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term follow-up observations of the therapeutic effect of PVNO on human silicosis.
    Zhao JD; Liu JD; Li GZ
    Zentralbl Bakteriol Mikrobiol Hyg B; 1983 Oct; 178(3):259-62. PubMed ID: 6659745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Change in the phospholipid status in experimental silicosis in rats and in exposure to polymeric preparations].
    Kupina LM
    Gig Tr Prof Zabol; 1978 Sep; (9):16-20. PubMed ID: 689453
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cytopharmacologic effect of using polyvinylpyridine-N-oxide in experimental silicosis].
    Arutiunov VD; Kruglikov GG; Batsura IuD; Fedorova VI
    Biull Eksp Biol Med; 1977 Mar; 83(3):371-4. PubMed ID: 856357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antisilicotic activity of various amides of polymethacrylic acid].
    Aronova GV; Borodulina SN; Katsnel'son BA; Postovskiĭ IIa; Chasovskikh OM
    Gig Tr Prof Zabol; 1982 Feb; (2):15-7. PubMed ID: 7068001
    [No Abstract]   [Full Text] [Related]  

  • 14. [Action of polyvinylpyridine N-oxide on individual lung tissue indices in experimental silicosis].
    Mukhina ST; Veretinskaia AG
    Gig Tr Prof Zabol; 1974 Oct; (10):33-5. PubMed ID: 4465165
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prophylactic action of polyvinylpyridine-N-oxide of different molecular weights on experimental silicosis].
    Bogdanskaia NI; Tolgskaia MS
    Gig Sanit; 1973 Apr; 38(4):102-4. PubMed ID: 4731236
    [No Abstract]   [Full Text] [Related]  

  • 16. [Behavior of the human liver during silicosis therapy using polyvinylpyridine-N-oxide (PVNO)].
    Haas P; Huber W
    Beitr Silikoseforsch Pneumokoniose; 1971; 23(3):91-100. PubMed ID: 5171411
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of inhalations of polyvinylpyridine-N-oxide on the development of experimental silicosis].
    Rodkina BS; Bolonova LN
    Farmakol Toksikol; 1979; 42(1):81-4. PubMed ID: 421895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Further study of the antisilicotic effectiveness of polypyridylethylmethacrylate phosphate].
    Aronova GV; Katsnel'son BA
    Gig Tr Prof Zabol; 1977; (6):49-51. PubMed ID: 892546
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antisilicosis activity of PVPO administered intratracheally and by inhalation (an experimental study)].
    Rodkina BS; Bolonova LN
    Gig Tr Prof Zabol; 1979 Sep; (9):32-6. PubMed ID: 535751
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental study of the antisilicotic effect of polyvinylpyridine-N-oxide].
    Katsnel'son BA; Babushkina LG; Aronova GV; Starikova SK; Pochashev EN
    Gig Sanit; 1970 Oct; 35(10):20-4. PubMed ID: 5507534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.